Universal Clinical Codes & Terminology Search

Oncology (solid tumor) gene expression profiling by real-time RT-PCR of 7 gene pathways (ER AR PI3K MAPK HH TGFB Notch) formalin-fixed paraffin-embedded (FFPE) algorithm reported as gene pathway activity score

Intramuscular autologous bone marrow cell therapy with preparation of harvested cells multiple injections one leg including ultrasound guidance if performed; complete procedure including unilateral or bilateral bone marrow harvest

Neurology (autism spectrum disorder [ASD]) quantitative measurements of 16 central carbon metabolites (ie a-ketoglutarate alanine lactate phenylalanine pyruvate succinate carnitine citrate fumarate hypoxanthine inosine malate S-sulfocysteine taurine urate and xanthine) liquid chromatography tandem mass spectrometry (LC-MS/MS) plasma algorithmic analysis with result reported as negative or positive (with metabolic subtypes of ASD)

Intramuscular autologous bone marrow cell therapy with preparation of harvested cells multiple injections one leg including ultrasound guidance if performed; complete procedure excluding bone marrow harvest

Rare diseases (constitutional/heritable disorders) identification of copy number variations inversions insertions translocations and other structural variants by optical genome mapping

Intramuscular autologous bone marrow cell therapy with preparation of harvested cells multiple injections one leg including ultrasound guidance if performed; unilateral or bilateral bone marrow harvest only for intramuscular autologous bone marrow cell therapy

Rare constitutional and other heritable disorders whole genome and mitochondrial DNA sequence analysis blood frozen and formalin-fixed paraffin-embedded (FFPE) tissue saliva buccal swabs or cell lines identification of single nucleotide and copy number variants

Implantation or replacement of carotid sinus baroreflex activation device; total system (includes generator placement unilateral or bilateral lead placement intra-operative interrogation programming and repositioning when performed)

Unexplained constitutional or other heritable disorders or syndromes tissue-specific gene expression by whole-transcriptome and next-generation sequencing blood formalin-fixed paraffin-embedded (FFPE) tissue or fresh frozen tissue reported as presence or absence of splicing or expression changes

Implantation or replacement of carotid sinus baroreflex activation device; lead only unilateral (includes intra-operative interrogation programming and repositioning when performed)

Rare constitutional and other heritable disorders identification of copy number variations inversions insertions translocations and other structural variants by optical genome mapping and whole genome sequencing

Implantation or replacement of carotid sinus baroreflex activation device; pulse generator only (includes intra-operative interrogation programming and repositioning when performed)

Hematology (atypical hemolytic uremic syndrome [aHUS]) genomic sequence analysis of 15 genes blood buccal swab or amniotic fluid

Revision or removal of carotid sinus baroreflex activation device; total system (includes generator placement unilateral or bilateral lead placement intra-operative interrogation programming and repositioning when performed)

Hematology (autosomal dominant congenital thrombocytopenia) genomic sequence analysis of 14 genes blood buccal swab or amniotic fluid

Revision or removal of carotid sinus baroreflex activation device; lead only unilateral (includes intra-operative interrogation programming and repositioning when performed)

Hematology (congenital coagulation disorders) genomic sequence analysis of 20 genes blood buccal swab or amniotic fluid

Revision or removal of carotid sinus baroreflex activation device; pulse generator only (includes intra-operative interrogation programming and repositioning when performed)

Hematology (congenital neutropenia) genomic sequence analysis of 23 genes blood buccal swab or amniotic fluid

Interrogation device evaluation (in person) carotid sinus baroreflex activation system including telemetric iterative communication with the implantable device to monitor device diagnostics and programmed therapy values with interpretation and report (eg battery status lead impedance pulse amplitude pulse width therapy frequency pathway mode burst mode therapy start/stop times each day);